SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 142 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,210,000 | -9.2% | 123,428 | 0.0% | 0.30% | -4.5% |
| Q4 2016 | $1,333,000 | +10.0% | 123,428 | +4.4% | 0.31% | +12.1% |
| Q3 2016 | $1,212,000 | -5.3% | 118,228 | +20.6% | 0.28% | -10.3% |
| Q2 2016 | $1,280,000 | +65.6% | 98,006 | +39.5% | 0.31% | +48.6% |
| Q1 2016 | $773,000 | +12.0% | 70,238 | -6.4% | 0.21% | +21.4% |
| Q4 2015 | $690,000 | +16.6% | 75,038 | +0.9% | 0.17% | +9.5% |
| Q3 2015 | $592,000 | -9.9% | 74,338 | +0.0% | 0.16% | -31.6% |
| Q2 2015 | $657,000 | +3.6% | 74,336 | +3.9% | 0.23% | -6.9% |
| Q1 2015 | $634,000 | +1.1% | 71,563 | -0.0% | 0.25% | -3.5% |
| Q4 2014 | $627,000 | +27.2% | 71,569 | 0.0% | 0.26% | +32.5% |
| Q3 2014 | $493,000 | +33.2% | 71,569 | -4.0% | 0.19% | +1.6% |
| Q2 2013 | $370,000 | – | 74,545 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |